Kirkland Advises TJC on Sale of Worldwide Clinical Trials

Kirkland & Ellis advised private equity firm TJC and its affiliate company Worldwide Clinical Trials on the sale of the contract research organization to private equity firm Kohlberg & Company, LLC. The deal was announced August 7 and is expected to close in the fourth quarter of 2023. TJC will hold onto a meaningful minority equity stake in Worldwide Clinical Trials, which works in partnership with biotechnology and pharmaceutical companies to create customized solutions to advance new medications from discovery to reality.

Read the transaction press release

The Kirkland team was led by corporate partners Michael Weisser, Lukas Richards and Ned Schultheis and associates Oliver Yee, D. Kim Grinhaus and Ahmed Imam; tax partner Jared Rusman and associate Liz Allison; executive compensation partner Mike Krasnovsky and associate Annemarie Mierzejewski; and debt finance partners Jason Serlenga and Katie Taylor.